Anal squamous cell carcinoma

Show results for

Unknown (201)
Transcriptomics (24)
Clinical (18)
Genomics (12)
Metabolomics (7)
Proteomics (5)

Organisms

Homo sapiens (25)
Camponotus floridanus (5)
Plasmodium falciparum 58.1 (5)
Solenopsis invicta (5)
Japanese encephalitis virus (5)
West Nile virus (5)
Culex pipiens pipiens (5)
Camponotus fellah (5)
Mycoplasmoides pneumoniae 19294 (5)
Xenopsylla cheopis (5)
NEWT:1313166 (5)
Hydra vulgaris (5)
Fusobacterium nucleatum subsp. nucleatum ATCC 25586 (5)
Angiostrongylus (5)
Nitrospinota (5)
Hadronyche infensa (5)
Myzus persicae persicae (5)
Equisetum arvense (5)
Xenopus tropicalis (5)
Influenza B virus (B/Memphis/13/2003) (5)
NEWT:1408434 (5)
Dengue virus (5)
Influenza A virus (A/Viet Nam/1203/2004(H5N1)) (5)
Mrakia psychrophila (5)
Lactococcus cremoris subsp. cremoris MG1363 (5)
uncultured Clostridium sp. (5)
Toxoplasma gondii PRU (5)
Mus musculus (4)
Rattus norvegicus (1)
Danio rerio (1)

Organisms

Homo sapiens (4)

Repository

biostudies-arrayexpress (21)
EGA (7)
MetaboLights (7)
pride (5)
ENA (5)
geo (3)

Tissue

Anal canal (2)
Epithelial cell (2)
Keratinocyte (1)
Fibroblast (1)
Cell culture (1)

Disease

Carcinoma (10)
Anal Cancer (2)
Squamous Cell Carcinoma of Head and Neck (2)
Normal (1)
Mesothelioma (1)
Carcinoma, Ovarian Epithelial (1)
Carcinoma, Squamous Cell (1)
Colorectal Neoplasms (1)
Anal canal squamous cell carcinoma (1)
Oral squamous cell carcinoma (1)
Anal canal cancer (1)
Squamous cell carcinoma (1)

Technology Type

Mass spectrometry (7)
Mass Spectrometry (5)
Shotgun proteomics (3)
All-ion fragmentation (1)
Data-dependent acquisition (1)
Bottom-up proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
STAR v2.5.3a, rpkmforgenes, RSeQC 2.6.1 (1)
Illumina Nextera XT index kits (Set A–D) (1)
Oligo(dT) primer and SuperScript II reverse transcriptase (ThermoFisher Scientific), TapeStation 4200 or 2100 Bioanalyzer with a DNA High Sensitivity chip (Agilent Biotechnologies) (1)
Aria III (BD Biosciences) (1)
Single cells were captured using the 10x Genomics Chromium Controller. (1)
Illumina HiSeq 3000 (1)
LTQ Orbitrap XL ETD (1)
Exactive (1)
Autoflex speed smartbeam (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Q Exactive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2024 (4)
2016 (4)
2014 (4)
2010 (4)
2026 (3)
2012 (3)
2011 (3)
2023 (2)
2019 (2)
2018 (1)
2009 (1)
2007 (1)
2025 (1)
2022 (1)
2017 (1)
2021 (1)

CHEBI ID

CHEBI:73218 (2)
CHEBI:74965 (2)
CHEBI:36259 (2)
CHEBI:18300 (2)
CHEBI:17151 (2)
CHEBI:17310 (2)
CHEBI:24149 (2)
CHEBI:17752 (2)
CHEBI:82966 (2)
CHEBI:27410 (2)
CHEBI:16753 (2)
CHEBI:16709 (2)
CHEBI:29016 (2)
CHEBI:9347 (2)
CHEBI:7916 (2)
CHEBI:28315 (2)
CHEBI:41321 (2)
CHEBI:16335 (2)
CHEBI:16708 (2)
CHEBI:17568 (2)
CHEBI:16750 (2)
CHEBI:55328 (2)
CHEBI:17645 (2)
CHEBI:9410 (2)
CHEBI:16914 (2)
CHEBI:17368 (2)
CHEBI:27471 (2)
CHEBI:15756 (2)
CHEBI:57458 (1)
CHEBI:39074 (1)

Metabolite Name

Arginine (3)
4-acetamidobutanoate (3)
Fructose 1,6-bisphosphate (2)
9-hydroxystearate (2)
Beta-citrylglutamate (2)
Hydantoin-5-propionate (2)
Decanoylcarnitine (C10) (2)
Propionylcarnitine (C3) (2)
Glycodeoxycholate (2)
Glycochenodeoxycholate (2)
3-hydroxydecanoylcarnitine (2)
N,N-dimethylalanine (2)
4-acetamidobenzoate (2)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (2)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (2)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (2)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)* (2)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)* (2)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (2)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)* (2)
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)* (2)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (2)
Palmitoyl dihydrosphingomyelin (d18:0/16:0)* (2)
1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) (2)
Behenoyl sphingomyelin (d18:1/22:0)* (2)
N-acetylmethionine sulfoxide (2)
2-aminophenol sulfate (2)
Guaiacol sulfate (2)
(R)-3-hydroxybutyrylcarnitine (2)
Lanthionine (2)

First Public Date

2024 (2)
2025 (1)
2020 (1)
2018 (1)

Study status

Completed (7)
Recruiting (6)
Active, not recruiting (2)
Withdrawn (1)
Not yet recruiting (1)
Not provided (1)

Study type

Interventional (18)
Transcription profiling by array (12)
Unknown experiment type (3)
RNA-seq of coding RNA from single cells (2)
RNA-seq of coding RNA (2)
Transcription profiling by RT-PCR (1)
Single nucleus RNA sequencing (1)

Release Date

2024 (32)
2020 (25)
2025 (23)
2023 (23)
2021 (23)
2022 (22)
2017 (13)
2019 (12)
2016 (11)
2018 (9)
2026 (6)
2014 (6)
2010 (4)
2015 (4)
2012 (3)
2011 (3)
2009 (1)
2007 (1)
2013 (1)

Lab affiliation

Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain (1)
Molecular and Translational Immunology Laboratory, Clinical Biochemistry and Immunology Department, Pharmacy Faculty, Universidad de Concepción, Concepción, Chile (1)
Biochemistry, University of Turku, Turku, Finland (1)
Department of Dermatology, University of Turku, Turku, Finland (1)
Head of Department (Pathology), University of Liege, Liege, Belgium (1)

Location

United States (12)
Australia (5)
Spain (4)
Denmark (3)
France (3)
Italy (3)
Canada (3)
United Kingdom (3)
Norway (2)
Taiwan (2)
Africa (1)
Oceania (1)
South America (1)
Guam (1)
South Africa (1)
Ireland (1)
Hong Kong (1)
Asia except Japan (1)
Portugal (1)
Colombia (1)
Europe (1)
North America (1)
Singapore (1)
Chile (1)
Mexico (1)
Philippines (1)
Russia (1)
South Korea (1)
Japan (1)
Germany (1)

Keyword

Tislelizumab (3)
Pembrolizumab (3)
Inoperable (2)
HNSCC (2)
Carboplatin (2)
CRC (2)
Cetuximab (2)
Cancer of the anus (1)
SCCA (1)
Cisplatin-5FU (1)
Carboplatin-Paclitaxel (1)
Endoscopic (1)
Outpatient (1)
Locally recurrent (1)
Electroporation (1)
7-hydroxystaurosporine (1)
Anal cancer (1)
DUET-4 (1)
Metastatic solid tumors (1)
Lymphocyte-activation gene 3 (LAG3) (1)
Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) (1)
Squamous Cell Anal Carcinoma (1)
CSCC (1)
ASCC (1)
NKTR-255 (1)
Hepatocellular/Liver Cancer (1)
INCB106385 (1)
Microsatellite instability (MSI) (1)
Mismatch repair (MMR) (1)
PMMR (1)

Previous page
1 / 27
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 27
Next page

Sort by:

Relevance

Page size

Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma

Anal squamous cell carcinoma (ASCC) is an infrequent tumor. Since 70s, treatment of stages II-III consists on a combination of 5-fluorouracil (5FU), mitomycin C (MMC), and radiotherapy. The aim of this study is the identification of biomarkers that allow personalized treatment and improvement of the...

ORGANISM(S): Homo sapiens (Human)

2023-04-26 | PXD037816 | Pride

Anal Canal Cancer : subclassification

Etiologically linked to HPV infection, malignancies of the anal canal have substantially increased in incidence over the last 20 years. Although most anal squamous cell carcinomas (SCC) respond well to chemoradiotherapy, for undetermined reasons, a subgroup of patients experience a poor outcome. Des...

ORGANISM(S): Homo sapiens (Human)

2016-12-20 | PXD004859 | Pride

Transitionnal zone Anal Hpv

Homo sapiens

Anal Squamous Cell Carcinoma (ASCC) Exome Sequencing

PRJNA412145 | ENA

Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

PRJNA1069754 | ENA

Intraocular metastasis from an anal squamous cell carcinoma: a case report.

Not available

S-EPMC12780632 | biostudies-literature

Endoscopic submucosal dissection to treat squamous cell carcinoma in situ of the anal canal.

Not available

S-EPMC9174080 | biostudies-literature

Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice.

Not available

S-EPMC8568287 | biostudies-literature

Transcription profiling of human squamous lung cancer cells vs normal cells to identify genes that are differentially regulated

Gene expression profile of squamous lung cancer cells are used to identify genes that are differentially regulated. Experiment Overall Design: Each pair of samples represent a single patient with squamous lung cancer. One is derived from the cancer cells, and the other is from the normal cells. Fi...

ORGANISM(S): Homo sapiens

2007-09-05 | E-GEOD-3268 | biostudies-arrayexpress

POG_patient_23739 - samples

Genome and transcriptome sequence data from a squamous cell carcinoma of anal canal patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

EGAD00001002582 | EGA

Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification.

Not available

S-EPMC7124473 | biostudies-literature

Previous page
1 / 27
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 27
Next page

Sort by:

Relevance

Page size

267 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets